Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 250 de 371.

Grafa

Protagonist Therapeutics shares surge as FDA approves J&J-partnered psoriasis drug

Protagonist Therapeutics (NASDAQ:PTGX) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 and older weighing at least 40 kg.

Leia mais: Protagonist Therapeutics shares surge as FDA approves J&J-partnered psoriasis drug
Grafa
Technology

Trump administration defends Anthropic blacklist, citing national security over speech

The Trump administration formally defended the Pentagon’s blacklisting of Anthropic in a Tuesday court filing, asserting that the designation of the artificial intelligence firm as a national security threat was both justified and lawful.

Leia mais: Trump administration defends Anthropic blacklist, citing national security over speech